Related Experiment Video
Updated: Jul 8, 2026

Optimized PCR-based Detection of Mycoplasma
Published on: June 20, 2011
High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients
R Y Wang1, J W Shih, T Grandinetti
1Department of Infectious and Parasitic Disease Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000.
Abstract:
Mycoplasma penetrans, a novel mycoplasma isolated from HIV-1-infected patients with AIDS, has pathogenic properties associated with in-vivo virulence. Enzyme-linked immunosorbent assay and western blotting detected a more than 100 times higher frequency of antibodies to the mycoplasma in serum from HIV-1-infected patients with AIDS (40%) than from HIV-negative controls (0.3%). Serum from 20% of HIV-1-infected, symptom-free individuals also had M penetrans specific antibodies. The antibodies' major immunoreactivity was directed against P35 and P38, the two main lipid-associated membrane protein antigens of the organism. Patients attending sexually transmitted disease clinics had a low frequency of antibody (0.9%). None of 178 HIV-negative patients with different non-AIDS diseases, many associated with immune dysfunction and/or low white cell counts, tested positive for the antibodies. M penetrans, apparently not a commensal and not a simple opportunist, is uniquely associated with HIV-1 infection and AIDS.
Insights
Mycoplasma penetrans antibodies are significantly more common in individuals with HIV-1 infection and AIDS. This novel mycoplasma is uniquely linked to HIV-1 and AIDS, not a typical opportunistic infection.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Mycoplasma penetrans is a novel mycoplasma identified in patients with Human Immunodeficiency Virus type 1 (HIV-1) infection and Acquired Immunodeficiency Syndrome (AIDS).
- This microorganism exhibits pathogenic properties and in-vivo virulence, suggesting a significant role in disease progression.
Purpose of the Study:
- To investigate the association between Mycoplasma penetrans and HIV-1 infection.
- To determine the prevalence of antibodies against M. penetrans in different patient groups.
- To identify the specific antigens of M. penetrans that elicit an immune response.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) and Western blotting were employed to detect antibodies.
- Serum samples were analyzed from HIV-1 infected patients with AIDS, HIV-1 infected asymptomatic individuals, patients from sexually transmitted disease clinics, and HIV-negative controls with various non-AIDS diseases.
Main Results:
- Antibodies to M. penetrans were detected in 40% of HIV-1 infected patients with AIDS, compared to only 0.3% in HIV-negative controls.
- Antibodies were also found in 20% of asymptomatic HIV-1 infected individuals.
- Major immunoreactivity was observed against P35 and P38, key lipid-associated membrane proteins of M. penetrans.
- A low antibody frequency (0.9%) was noted in patients from STD clinics, and no antibodies were found in 178 HIV-negative individuals with other conditions.
Conclusions:
- Mycoplasma penetrans is uniquely associated with HIV-1 infection and AIDS.
- The organism does not appear to be a commensal or a simple opportunistic pathogen.
- The presence of M. penetrans antibodies strongly correlates with HIV-1 status and disease severity.
Related Concept Videos
Atypical Pneumonia
Cryptococcal Meningitis
Trichomoniasis

